Concepedia

Author

Michelle Moorhouse

University of the WitwatersrandORCID

Also Known As

M Moorhouse, M. Moorhouse, Megan A. M. Moorhouse, Michelle A. Moorhouse, Michelle Moorhouse

65

Publications

2.5K

Citations

21

H-Index

52

Concepts

All Affiliations

University of the WitwatersrandUniversity of Cape TownPerinatal HIV Research UnitUniversity Medical Center UtrechtUniversity of Liverpool
MM

About

Michelle Moorhouse is an author at University of the Witwatersrand specializing in medicine, hiv, and preventive medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

15

1K

2

Public Health

10

10

552

3

Nursing

3

3

117

4

Social Sciences

3

3

137

5

Health Sciences

2

2

63

Michelle Moorhouse

×

32

Publications

2.4K

Citations

20

H-Index

YearCitations

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

François Venter, Michelle Moorhouse, Simiso Sokhela,

New England Journal of Medicine

2019

684

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

François Venter, Simiso Sokhela, Bryony Simmons,

The Lancet HIV

2020

249

Adult antiretroviral therapy guidelines 2017

Graeme Meintjes, Michelle Moorhouse, Sergio Carmona,

Southern African Journal of HIV Medicine

2017

190

Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study

Lucas E. Hermans, Michelle Moorhouse, Sergio Carmona,

The Lancet Infectious Diseases

2017

163

HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project

Robyn Eakle, Gabriela B. Gomez, Niven Naicker,

PLoS Medicine

2017

159

Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection

Linda‐Gail Bekker, Kevin Rebe, François Venter,

Southern African Journal of HIV Medicine

2016

103

<i>CYP2B6</i> Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz

Rulan Griesel, Gary Maartens, Maxwell Chirehwa,

Clinical Infectious Diseases

2020

81

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase

Mark J. Siedner, Michelle Moorhouse, Bryony Simmons,

Nature Communications

2020

81

Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update

Jeremy Nel, Sipho Dlamini, Graeme Meintjes,

Southern African Journal of HIV Medicine

2020

76

Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes

Michelle Moorhouse, Gary Maartens, François Venter,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2018

54

Page 1